Min-Jung Lee

5.0k total citations
96 papers, 2.8k citations indexed

About

Min-Jung Lee is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Min-Jung Lee has authored 96 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 29 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Min-Jung Lee's work include Histone Deacetylase Inhibitors Research (13 papers), Heat shock proteins research (10 papers) and Ovarian cancer diagnosis and treatment (7 papers). Min-Jung Lee is often cited by papers focused on Histone Deacetylase Inhibitors Research (13 papers), Heat shock proteins research (10 papers) and Ovarian cancer diagnosis and treatment (7 papers). Min-Jung Lee collaborates with scholars based in United States, South Korea and Japan. Min-Jung Lee's co-authors include Jane B. Trepel, Sunmin Lee, Len Neckers, Yusuke Tomita, Yunjin Jung, Eun Joo Chung, Eun-Joo Chung, Monica G. Marcu, William D. Figg and William Burgan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Min-Jung Lee

90 papers receiving 2.8k citations

Peers

Min-Jung Lee

ONCOL

IMMUN

PRM

James W. Jacobberger United States

Mathias Wilhelm Germany

Céline Lefèbvre France

Alessandro Datti Canada

Ken Garber United States

Raghothama Chaerkady United States

Susan A. Brooks United Kingdom

Fei Huang United States

Jinhua Wang United States

Ingo H. Engels Germany

James W. Jacobberger United States

Min-Jung Lee

2.0k ×1.1

769 ×1.2

ONCOL

563 ×1.4

IMMUN

461 ×1.2

PRM

353 ×1.5

Citations per year, relative to Min-Jung Lee Min-Jung Lee (= 1×) peers James W. Jacobberger

Countries citing papers authored by Min-Jung Lee

Since Specialization

Citations

This map shows the geographic impact of Min-Jung Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min-Jung Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min-Jung Lee more than expected).

Fields of papers citing papers by Min-Jung Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min-Jung Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min-Jung Lee. The network helps show where Min-Jung Lee may publish in the future.

Co-authorship network of co-authors of Min-Jung Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Min-Jung Lee. A scholar is included among the top collaborators of Min-Jung Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min-Jung Lee. Min-Jung Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Baechler, Simone A., Anjali Dhall, Hongliang Zhang, et al.. (2025). Topoisomerase III-beta protects from immune dysregulation and tumorigenesis. Science Advances. 11(51). eady7028–eady7028.

Peer, Cody J., Xianyu Zhang, Hyoyoung Choo‐Wosoba, et al.. (2024). Tofacitinib to prevent anti-drug antibody formation against LMB-100 immunotoxin in patients with advanced mesothelin-expressing cancers. Frontiers in Oncology. 14. 1386190–1386190. 3 indexed citations

Greer, Yoshimi Endo, Sarah M. Jenkins, Margaret E. Gatti‐Mays, et al.. (2023). A Single-Arm, Open-Label Phase II Study of ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma. The Oncologist. 28(10). 919–e972. 6 indexed citations

Surman, Deborah R., Yue Xu, Min-Jung Lee, et al.. (2021). Therapeutic Synergy in Esophageal Cancer and Mesothelioma Is Predicted by Dynamic BH3 Profiling. Molecular Cancer Therapeutics. 20(8). 1469–1480. 4 indexed citations

Connolly, Roisín M., Fengmin Zhao, Kathy D. Miller, et al.. (2021). E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor–Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group. Journal of Clinical Oncology. 39(28). 3171–3181. 76 indexed citations

Lee, Seung‐Jun, Jinah Park, Dong‐Joon Lee, et al.. (2020). Mast4 knockout shows the regulation of spermatogonial stem cell self-renewal via the FGF2/ERM pathway. Cell Death and Differentiation. 28(5). 1441–1454. 17 indexed citations

Ripley, R. Taylor, Deborah R. Surman, Laurence P. Diggs, et al.. (2018). Metabolomic and BH3 profiling of esophageal cancers: novel assessment methods for precision therapy. BMC Gastroenterology. 18(1). 94–94. 6 indexed citations

Nahm, Minyeop, Min-Jung Lee, Young-Eun Kim, et al.. (2017). The Rap activator Gef26 regulates synaptic growth and neuronal survival via inhibition of BMP signaling. Molecular Brain. 10(1). 62–62. 10 indexed citations

Ogawa, Mikako, Yusuke Tomita, Yuko Nakamura, et al.. (2017). Immunogenic cancer cell death selectively induced by near infrared photoimmunotherapy initiates host tumor immunity. Oncotarget. 8(6). 10425–10436. 195 indexed citations

10.

Yuno, Akira, et al.. (2017). Clinical Evaluation and Biomarker Profiling of Hsp90 Inhibitors. Methods in molecular biology. 1709. 423–441. 97 indexed citations

11.

Wood, Lauren V., Antonio Tito Fojo, William L. Dahut, et al.. (2016). TARP vaccination is associated with slowing in PSA velocity and decreasing tumor growth rates in patients with Stage D0 prostate cancer. OncoImmunology. 5(8). e1197459–e1197459. 25 indexed citations

12.

Connolly, Roisín M., Fengmin Zhao, Kathy Ann Miller, et al.. (2015). E2112: Randomized phase III trial of endocrine therapy plus entinostat/placebo in patients with hormone receptor-positive advanced breast cancer.. Journal of Clinical Oncology. 9 indexed citations

13.

Luger, Dror, Yu-an Yang, Douglas S. Weinberg, et al.. (2013). Expression of the B-Cell Receptor Component CD79a on Immature Myeloid Cells Contributes to Their Tumor Promoting Effects. PLoS ONE. 8(10). e76115–e76115. 47 indexed citations

14.

Noh, Hyung-Jun, et al.. (2012). Antioxidant activity and Cancer cell growth inhibition of Ganoderma lucidum. Journal of Mushrooms. 10(4). 203–207. 3 indexed citations

15.

Kong, Hyesik, Sunmin Lee, Kristin Beebe, et al.. (2010). Emetine Promotes von Hippel-Lindau-Independent Degradation of Hypoxia-Inducible Factor-2α in Clear Cell Renal Carcinoma. Molecular Pharmacology. 78(6). 1072–1078. 18 indexed citations

16.

Lee, Min-Jung, et al.. (2009). A Case of the Giant and Hyperkeratotic Variant of Porokeratosis.. Linchuang pifuke zazhi. 47(1). 101–103. 1 indexed citations

17.

Lee, Min-Jung, et al.. (2009). Analysis of Physical, Chemical and Biological Parameters, Based on Long-Term Monitoring (2004 $\sim$ 2007), in Daejeon Stream. Journal of Ecology and Environment. 42(3). 364–373. 1 indexed citations

18.

Lee, Min-Jung, et al.. (2004). Analysis and Modeling of Semantic Relationships in e-Catalog Domain. The e-Business Studies. 9(3). 243–258. 3 indexed citations

19.

Park, Hae‐Young, Jiyeon Park, Min-Jung Lee, et al.. (2004). Differential expression of dendritic cell markers by all-trans retinoic acid on human acute promyelocytic leukemic cell line. International Immunopharmacology. 4(13). 1587–1601. 11 indexed citations

20.

Lee, Min-Jung, et al.. (2003). A Study on Uniform Design Applied Orientalism. Fashion & Textile Research Journal. 5(5). 443–452. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact